Eric Hunter is Professor of Pathology and Laboratory Medicine at Emory University, Co-Director Emeritus of the Emory Center for AIDS Research, and a Georgia Research Alliance Eminent Scholar. Until 2004, he was Professor of Microbiology at the University of Alabama at Birmingham, where he was the founding Director of the UAB Center for AIDS Research, guiding its growth over 16 years into one of the leading AIDS research institutions in the United States. He served until 2010 as Chair of the AIDS Vaccine Research Subcommittee and as Editor in Chief of the journal AIDS Research and Human Retroviruses. He serves on the editorial boards of several academic journals and the external advisory committees of several academic and commercial institutions. His career included undergraduate studies in bacteriology at Birmingham University, England, and graduate work in tumor immunology carried out at the Imperial Cancer Research Fund & Brunel University, London, England. During postdoctoral studies at the University of Southern California and following his move to UAB, he pioneered molecular genetics approaches to examine retrovirus replication. His research is primarily centered on understanding the host and viral factors that modulate HIV heterosexual transmission and early viral disease in African populations with the goal of applying this knowledge to HIV vaccine development.
Eric Hunter is Professor of Pathology and Laboratory Medicine at Emory University, Co-Director Emeritus of the Emory Center for AIDS Research, and a Georgia Research Alliance Eminent Scholar. Until 2004, he was Professor of Microbiology at the University of Alabama at Birmingham, where he was the founding Director of the UAB Center for AIDS Research, guiding its growth over 16 years into one of the leading AIDS research institutions in the United States. He served until 2010 as Chair of the AIDS Vaccine Research Subcommittee and as Editor in Chief of the journal AIDS Research and Human Retroviruses. He serves on the editorial boards of several academic journals and the external advisory committees of several academic and commercial institutions. His career included undergraduate studies in bacteriology at Birmingham University, England, and graduate work in tumor immunology carried out at the Imperial Cancer Research Fund & Brunel University, London, England. During postdoctoral studies at the University of Southern California and following his move to UAB, he pioneered molecular genetics approaches to examine retrovirus replication. His research is primarily centered on understanding the host and viral factors that modulate HIV heterosexual transmission and early viral disease in African populations with the goal of applying this knowledge to HIV vaccine development.